Cargando…
Serum S100B Represents a New Biomarker for Mood Disorders
Recently, mood disorders have been discussed to be characterized by glial pathology. The protein S100B, a growth and differentiation factor, is located in, and may actively be released by astro- and oligodendrocytes. This protein is easily assessed in human serum and provides a useful parameter for...
Autores principales: | Schroeter, Matthias L., Sacher, Julia, Steiner, Johann, Schoenknecht, Peter, Mueller, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821390/ https://www.ncbi.nlm.nih.gov/pubmed/23701298 http://dx.doi.org/10.2174/13894501113149990014 |
Ejemplares similares
-
Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies
por: Schroeter, Matthias L., et al.
Publicado: (2010) -
Validating Serum S100B and Neuron-Specific Enolase as Biomarkers for the Human Brain – A Combined Serum, Gene Expression and MRI Study
por: Streitbürger, Daniel-Paolo, et al.
Publicado: (2012) -
Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment
por: Polyakova, Maryna, et al.
Publicado: (2022) -
Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression Analysis
por: Schümberg, Katharina, et al.
Publicado: (2016) -
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance
por: Steiner, Johann, et al.
Publicado: (2010)